Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer. Orellana TJ, Kim H, Beriwal S, Taylor SE, et al. Gynecol Oncol 2023;173:81-87.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Orellana TJ, Kim H, Beriwal S, Taylor SE, et al. Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer. Gynecol Oncol 2023;173:81-87.
PMID: 37105061